These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17210141)

  • 1. Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study.
    Praschak-Rieder N; Kennedy J; Wilson AA; Hussey D; Boovariwala A; Willeit M; Ginovart N; Tharmalingam S; Masellis M; Houle S; Meyer JH
    Biol Psychiatry; 2007 Aug; 62(4):327-31. PubMed ID: 17210141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain.
    Murthy NV; Selvaraj S; Cowen PJ; Bhagwagar Z; Riedel WJ; Peers P; Kennedy JL; Sahakian BJ; Laruelle MA; Rabiner EA; Grasby PM
    Neuroimage; 2010 Aug; 52(1):50-4. PubMed ID: 20406689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midbrain serotonin transporter binding potential measured with [11C]DASB is affected by serotonin transporter genotype.
    Reimold M; Smolka MN; Schumann G; Zimmer A; Wrase J; Mann K; Hu XZ; Goldman D; Reischl G; Solbach C; Machulla HJ; Bares R; Heinz A
    J Neural Transm (Vienna); 2007; 114(5):635-9. PubMed ID: 17225932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of serum BDNF levels on central serotonin transporter availability in obese versus non-obese adults: A [(11)C]DASB positron emission tomography study.
    Hinderberger P; Rullmann M; Drabe M; Luthardt J; Becker GA; Blüher M; Regenthal R; Sabri O; Hesse S
    Neuropharmacology; 2016 Nov; 110(Pt A):530-536. PubMed ID: 27108933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of the serotonin transporter gene promoter polymorphism (5-HTTLPR) genotype and serotonin transporter binding to neural processing of negative emotional stimuli.
    Schneck N; Miller JM; Delorenzo C; Kikuchi T; Sublette ME; Oquendo MA; Mann JJ; Parsey RV
    J Affect Disord; 2016 Jan; 190():494-498. PubMed ID: 26561939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.
    Cannon DM; Ichise M; Rollis D; Klaver JM; Gandhi SK; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2007 Oct; 62(8):870-7. PubMed ID: 17678634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking moderates association of 5-HTTLPR and in vivo availability of serotonin transporters.
    Smolka MN; Reimold M; Kobiella A; Reischl G; Rietschel M; Heinz A
    Eur Neuropsychopharmacol; 2019 Dec; 29(2):171-178. PubMed ID: 30587400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BDNF val66met association with serotonin transporter binding in healthy humans.
    Fisher PM; Ozenne B; Svarer C; Adamsen D; Lehel S; Baaré WF; Jensen PS; Knudsen GM
    Transl Psychiatry; 2017 Feb; 7(2):e1029. PubMed ID: 28195567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.
    Meyer JH; Houle S; Sagrati S; Carella A; Hussey DF; Ginovart N; Goulding V; Kennedy J; Wilson AA
    Arch Gen Psychiatry; 2004 Dec; 61(12):1271-9. PubMed ID: 15583118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET.
    Shioe K; Ichimiya T; Suhara T; Takano A; Sudo Y; Yasuno F; Hirano M; Shinohara M; Kagami M; Okubo Y; Nankai M; Kanba S
    Synapse; 2003 Jun; 48(4):184-8. PubMed ID: 12687637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the impact of BDNF Val66Met genotype on serotonin transporter and serotonin-1A receptor binding.
    Kraus C; Baldinger P; Rami-Mark C; Gryglewski G; Kranz GS; Haeusler D; Hahn A; Wadsak W; Mitterhauser M; Rujescu D; Kasper S; Lanzenberger R
    PLoS One; 2014; 9(9):e106810. PubMed ID: 25188405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.
    Laje G; Cannon DM; Allen AS; Klaver JM; Peck SA; Liu X; Manji HK; Drevets WC; McMahon FJ
    Int J Neuropsychopharmacol; 2010 Jul; 13(6):715-24. PubMed ID: 20047709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography.
    Cannon DM; Ichise M; Fromm SJ; Nugent AC; Rollis D; Gandhi SK; Klaver JM; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2006 Aug; 60(3):207-17. PubMed ID: 16875929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.
    Bhagwagar Z; Murthy N; Selvaraj S; Hinz R; Taylor M; Fancy S; Grasby P; Cowen P
    Am J Psychiatry; 2007 Dec; 164(12):1858-65. PubMed ID: 18056241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal changes in brain serotonin transporter binding in short serotonin transporter linked polymorphic region-allele carriers but not in long-allele homozygotes.
    Kalbitzer J; Erritzoe D; Holst KK; Nielsen FA; Marner L; Lehel S; Arentzen T; Jernigan TL; Knudsen GM
    Biol Psychiatry; 2010 Jun; 67(11):1033-9. PubMed ID: 20110086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminished brain 5-HT transporter binding in major depression: a positron emission tomography study with [11C]DASB.
    Selvaraj S; Murthy NV; Bhagwagar Z; Bose SK; Hinz R; Grasby PM; Cowen PJ
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):555-62. PubMed ID: 19756523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography study.
    Hesse S; Rullmann M; Luthardt J; Winter K; Hankir MK; Becker GA; Zientek F; Reissig G; Regenthal R; Drabe M; Schinke C; Bresch A; Arelin K; Lobsien D; Patt M; Meyer PM; Fasshauer M; Fenske WK; Blüher M; Stumvoll M; Sabri O
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1096-104. PubMed ID: 26577939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study.
    Matsumoto R; Ichise M; Ito H; Ando T; Takahashi H; Ikoma Y; Kosaka J; Arakawa R; Fujimura Y; Ota M; Takano A; Fukui K; Nakayama K; Suhara T
    Neuroimage; 2010 Jan; 49(1):121-6. PubMed ID: 19660554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic contributions to brain serotonin transporter levels in healthy adults.
    Bruzzone SEP; Nasser A; Aripaka SS; Spies M; Ozenne B; Jensen PS; Knudsen GM; Frokjaer VG; Fisher PM
    Sci Rep; 2023 Sep; 13(1):16426. PubMed ID: 37777558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV.
    Hammoud DA; Endres CJ; Hammond E; Uzuner O; Brown A; Nath A; Kaplin AI; Pomper MG
    Neuroimage; 2010 Feb; 49(3):2588-95. PubMed ID: 19853044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.